BioAge Labs, Inc.
BIOA
$4.51
-$0.10-2.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.86M | 1.45M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.86M | 1.45M | -- | -- | -- |
| Cost of Revenue | 30.95M | 21.58M | 19.79M | 19.79M | 19.79M |
| Gross Profit | -27.09M | -20.13M | -19.79M | -19.79M | -19.79M |
| SG&A Expenses | 25.00M | 22.45M | 19.16M | 16.54M | 15.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 95.19M | 83.28M | 78.19M | 66.43M | 51.57M |
| Operating Income | -91.33M | -81.83M | -78.19M | -66.43M | -51.57M |
| Income Before Tax | -79.03M | -71.05M | -71.11M | -70.94M | -62.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -79.03 | -71.05 | -71.11 | -70.94 | -62.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -79.03M | -71.05M | -71.11M | -70.94M | -62.16M |
| EBIT | -91.33M | -81.83M | -78.19M | -66.43M | -51.57M |
| EBITDA | -91.15M | -81.66M | -78.03M | -66.27M | -51.39M |
| EPS Basic | -8.25 | -15.58 | -22.99 | -34.93 | -36.97 |
| Normalized Basic EPS | -5.16 | -9.74 | -14.27 | -17.97 | -19.24 |
| EPS Diluted | -8.25 | -15.58 | -22.99 | -34.93 | -36.97 |
| Normalized Diluted EPS | -5.16 | -9.74 | -14.27 | -17.97 | -19.24 |
| Average Basic Shares Outstanding | 111.21M | 77.07M | 42.89M | 8.55M | 6.73M |
| Average Diluted Shares Outstanding | 111.21M | 77.07M | 42.89M | 8.55M | 6.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |